Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Cash (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Change in Cash for 2 consecutive years, with $6.5 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 12.32% to $6.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.1 million through Dec 2025, down 141.3% year-over-year, with the annual reading at -$4.1 million for FY2025, 141.3% down from the prior year.
  • Change in Cash for Q4 2025 was $6.5 million at Pyxis Oncology, up from -$1.8 million in the prior quarter.
  • The five-year high for Change in Cash was $18.3 million in Q1 2024, with the low at -$13.0 million in Q3 2024.